These results imply that TMED2 might play a pivotal role in the tumor immune microenvironment by regulating the characteristics of immune cells or the expression levels of immunoregulatory genes, thereby influencing cancer growth and response to treatment. The gene discussed is TMED2; the disease is neoplasm.